Nitrophorin 2 (NP2) is a salivary lipocalin from Rhodnius prolixus that binds with coagulation factors IX (fIX) and IXa (fIXa). Binding of NP2 with fIXa results in potent inhibition of the intrinsic factor Xase complex. A panel of site-directed surface mutants of NP2 was generated to locate determinants of high affinity fIX(a) binding. The locations of the mutations were based on comparisons with the related, but less potent, inhibitor nitrophorin 3 (NP3). Three point mutants (K21A, K92A, and V94A) were found that clearly reduced the inhibitory potency as measured by the activity of a reconstituted factor Xase system. Binding of NP2 with fIXa and fIX as measured by surface plasmon resonance and isothermal titration calorimetry was reduced in a similar manner. Of the three mutants, two (K92A and V94A) were located on the loop connecting ␤-strands E and F of the lipocalin ␤-barrel. The largest changes were seen with the K92A mutation, which lies at the apex of the loop, with a smaller effect being seen with mutation of Val 94 . Combination of four E-F loop mutations (K92A, A93K, V94A, E97A) in a single mutant reduced the inhibitory potency and binding to levels similar to those seen with NP3 without affecting heme or histamine binding.
The intrinsic factor Xase complex (fXase) 1 is an essential component of the mammalian blood coagulation cascade consisting of factors IXa (fIXa), VIIIa (fVIIIa), and X (fX) assembled on an anionic phospholipid surface (1) . Disruption of this reaction results in two of the most important human bleeding disorders, hemophilias A (fVIII deficiency) and B (fIX deficiency) (1) . Nitrophorin 2 (NP2) is a salivary anticoagulant protein from the blood-feeding insect Rhodnius prolixus that targets the intrinsic fXase complex (2, 3) . It is a hyperbolic mixed-type inhibitor that acts by interfering with assembly of the proteolytic complex and/or phospholipid binding (4) . NP2 does not inhibit the amidolytic activity of fIXa but rather blocks fXa formation in reactions lacking either phospholipid vesicles or fVIIIa (4) . Factor X activation is not inhibited in the absence of fVIIIa and phospholipid suggesting that interactions between fX and fIXa are not directly influenced by NP2, while those between fIXa and fVIIIa/phospholipid are (4) . Nevertheless, direct binding of NP2 with fIX and fIXa has been shown using surface plasmon resonance (SPR), while in the same study, no interaction of NP2 with fVIII was seen (5) . Binding with fIX also results in inhibition of fIXa generation by both fXIa and the tissue factor-fVIIa complex (5) . Removal of the Gla (␥-carboxyglutamic acid-rich) domain of fIX was found to eliminate the SPR interaction, suggesting that the NP2 binding site is located at or near this region, a primary point of interaction between fIXa and the phospholipid surface (5) and fVIIIa (6) .
NP2 is a member of the nitrophorin (NP) group, consisting of four related salivary lipocalins in R. prolixus that are remarkable in taking on numerous functions related to blood feeding (7) (8) (9) (10) . NPs are heme proteins that carry a molecule of nitric oxide from the salivary gland to the host circulation where it serves as a vasodilator and platelet aggregation inhibitor (7, 11) . Additionally, NPs bind histamine with high affinity, making them anti-inflammatory agents as well (8) . NP2 is unique among members of the group in being a potent coagulation inhibitor. NP3, the closest relative of NP2, has recently been shown to have weak anticoagulant activity while the remaining two well characterized NPs, NP1 and NP4, show no effect on clotting (12) .
We have previously described the crystal structure of NP2 and compared it with those of NP4 and NP1 (12) . Binding of histamine and NO occurs via coordination with heme iron, but the anticoagulant effect is independent of heme binding and appears to involve an exterior binding surface (2) . Differences in the molecular surfaces between NP1, NP4, and NP2 suggested that fIXa binding by NP2 may be related to exposure of a portion of the eight-stranded ␤-barrel consisting of parts of strands B, C, D, and E due to a shortened C terminus relative to NP1 and NP4 (12) . The less potent NP3 shares 80% sequence identity with NP2, and like NP2, its C-terminal is shortened, but the two molecules differ at a number of surface-exposed amino acid positions. In this study we have used structural information from NP2 as well as sequence comparisons between NP2 and NP3 to design a panel of site-directed mutants to locate a major determinant of high affinity fIXa binding by this unusual and potentially important inhibitor of the intrinsic coagulation pathway.
MATERIALS AND METHODS
Reagents-Coagulation factors IXa and X were obtained from Hematologic Technologies (Essex Junction, VT) or Enzyme Research Laboratories (South Bend, IN). Recombinant factor VIII was obtained from American Diagnostica (Greenwich, CT) or as the therapeutic agent Advate from Baxter Healthcare (Westlake Village, CA). The chromogenic substrate S-2222 was obtained from Diapharma (Columbus, OH), and phospholipids were obtained from Sigma. The Quick Change site directed mutagenesis system was from Stratagene (La Jolla, CA).
Mutagenesis Procedure and Preparation of Wild-type and Mutant Protein-Site-directed mutants of NP2 were generated either by a PCRbased procedure or with the QuikChange site-directed mutagenesis system. The DNA sequences of all mutants were verified. Mutated cDNAs were ligated into the expression vector pET17b and the Escherichia coli strain BL21(DE3)pLysS was used for expression. Proteins were obtained as inclusion bodies that were washed, solubilized in 20 mM Tris-HCl, pH 8, 6 M guanidinium hydrochloride containing 10 mM dithiothreitol, and refolded as described previously (9, 13) . After refolding, the proteins were reconstituted with heme and purified by a combination of gel filtration and cation exchange chromatography as described previously (9, 13) . Purified NPs were evaluated for purity and quantified by SDS-PAGE and UV-visible spectrophotometry.
Assay of the Intrinsic fIXase-Phospholipid vesicles were generated by injecting a mixture of phosphatidylcholine and phosphatidylserine (3/1 in chloroform) into 20 mM Tris-HCl, pH 7.4 at 70°C to a final concentration of 1 mM (11, 14) . Nitrogen was bubbled through the buffer during and for 10 min after injection. The vesicles were incubated at 70°C for 1 h and then allowed to cool to room temperature before use.
Enzymatic reactions were carried out in a final volume of 0.1 ml in 96-well microtiter plates. The reaction buffer contained 20 mM TrisHCl, pH 7.4, 150 mM NaCl, 2 mM CaCl 2 , and 10 M phosphatidylcholine/ phosphatidylserine (3:1) vesicles. Recombinant fVIII was added to a final concentration of 15 units/ml and activated by adding thrombin (0.1 unit/ml), followed by incubation for 3 min at room temperature. After fVIII activation NPs were added to various concentrations followed by addition of fIXa to a concentration of 0.25 nM. The reaction was started by adding fX to a concentration of 150 nM and then incubated for 4 min at 37°C. Reactions were stopped by adding EDTA to a concentration of 5 mM. fXa generation was determined by adding the substrate S-2222 in water directly to the wells to a final concentration of 180 M. Absorbance changes at 405 nm were measured at 25°C using a ThermoMax kinetic plate reader.
Surface Plasmon Resonance-SPR measurements were made with a Biacore 3000 instrument at 25°C. Factor IXa dissolved in 20 mM sodium acetate, pH 4.5, 0.15 M NaCl, 5 mM CaCl 2 was immobilized by passing over an activated CM5 chip at a flow rate of 20 l/min. For measurement of binding, NP2 and its mutants were dissolved in TrisHCl, pH 7.4, 0.15 M NaCl, 2 mM CaCl 2 . All data were collected using a flow rate of 20 l/min. The kinetic data were fitted to a two-state model including an induced fit-type conformational change (Scheme 1).
The Biacore evaluation software was used to obtain the rate constants k 1 , k Ϫ1 , k 2 , and k Ϫ2 by simultaneous global fitting to the rate equations,
where [fIXaNP*] represents the concentration of the encounter complex, and [fIXa-NP] represents concentration of the complex after stabilization by a conformational change. The dissociation constants for the two reaction steps (K d1 and K d2 ) and the overall dissociation constant (K do ) were calculated as follows (15) .
Isothermal Titration Calorimetry-Titrations measuring either histamine binding with various NPs or NP binding with fIXa were performed using a Microcal VP-ITC microcalorimeter at 30°C. The proteins were dialyzed against 20 mM Tris-HCl, pH 7.4, 0.15 M NaCl for histamine binding experiments. For measurement of NP2 interaction with fIXa, 2 mM CaCl 2 was added to the dialysis buffer. Histamine was dissolved in the buffer used for dialysis of the NP. In the case of histamine binding, wild-type NP2 or NP2 mutants were added to the cell, while histamine was delivered in 10-l injections. In fIXa studies, the coagulation factor was added to the cell, while NP was delivered in 5-10 l injections. Heats of dilution were subtracted from the data, and the net enthalpies were fitted to a single-site binding model using the Microcal-Origin software.
RESULTS
Mutagenesis Strategy-Candidate residues for site-directed mutagenesis of NP2 were identified by a two-step procedure. An alignment of NP2 and NP3 was created, and non-conserved amino acid positions were identified (Fig. 1) . The NP2 crystal structure (Protein Data Bank designation 1EUO) was then examined to find non-conserved residues having surface-exposed side chains. The set of non-conserved residues showing surface exposure in the crystallographic model was chosen for mutagenesis ( Fig. 1) . In most cases the residues were mutated to alanine, but in the case of residues 60, 93, and 142, the NP2 residue was mutated to the corresponding residue in NP3.
General Characterization of Point Mutants-All of the NP2 mutants tested here produced absorbance spectra similar to ligand-free and ligand-bound forms of wild-type protein (Fig. 2 , A-D) with Soret absorbances near 403 nm for the ligand-free proteins and at 410 nm for the histamine complexes. Histamine affinity measurements were made only for those mutants showing significantly reduced inhibitory activity in the fXase assay. The binding enthalpy for histamine was highly favorable, presumably due to coordination of the imidazole portion of histamine with ferric iron, as well as the formation of salt bridge and hydrogen bond interactions of protein side chains with the aliphatic amino group of histamine seen in published crystal structures of NP1 and NP4 (Fig. 2 , E and F). The histamine dissociation constants for the mutant and wild-type proteins were nearly identical and were similar to published values obtained by spectrophotometric methods (9, 16) . Taken together, the absorbance spectra and calorimetric data of the mutants indicate that the proteins are properly folded.
Inhibition of the Intrinsic fXase Complex by Wild-type NPs-NP2 strongly inhibited the fXase reaction, while NP4 showed no detectable inhibition and NP3 showed only weak activity (Fig. 3) . The IC 50 value for wild-type NP2 inhibition of the intrinsic Xase complex at a fixed concentration of fX was ϳ10 nM, nearly identical to the published K i value of 12 nM (5). For NP3 the IC 50 was 1.7 M, ϳ170-fold larger than that seen with NP2, and only partial inhibition was achievable (Fig. 4A) .
Inhibition of the fXase Complex by NP2 Mutants-Of the 17 NP2 point mutants tested, four showed a clear reduction in inhibitory potency relative to wild-type protein at a single inhibitor concentration of 80 nM (Fig. 3) . Mutants K92A and V94A were clearly less potent than the others, while K21A was only slightly less active than the wild-type protein (Figs. 3 and  4, A and B) . Mutants Lys 92 and Val 94 lie on the loop connecting strands E and F (E-F loop) of the eight-stranded lipocalin ␤-barrel (12), indicating that this loop is an important determinant for formation of a high affinity complex.
The point mutant K92A showed the largest loss of inhibitory potency, with the IC 50 value increasing ϳ35-fold over the wildtype (Fig. 4A) , followed by V94A, which produced a ϳ4-fold increase in the IC 50 (Fig. 4B) . The K21A mutant showed a small but detectable reduction in inhibition with an IC 50 values ϳ2-fold larger than wild-type, respectively. Interestingly, the A93K mutation, lying between Lys 92 and Val 94 on the E-F loop, had no detectable effect on inhibition (Fig. 3) , but the E97A mutant showed a slight decrease in potency (Fig. 3) . When the K92A, A93K, V94A, and E97A mutations were combined into a single quadruple mutant construct (QUAD), the loss of potency was larger than any single point mutant, with an increase in the IC 50 of ϳ160-fold (Figs. 3 and 4A ). The QUAD mutant was similar in potency to NP3 (Fig. 4A ), and as with NP3, only partial inhibition was achievable.
SPR Analysis Suggests a Two-state Binding Model-We observed multiphasic kinetics for both association and dissociation reactions of NP2 with immobilized fIXa. The kinetic behavior was not affected by changes in ligand loading or flow rate, suggesting that mass transfer effects were not responsible. An experiment was performed in which the contact time of an analyte (K92A mutant) was varied at a single concentration. The observed reduction in amplitude of the fast release phase (k Ϫ1 ) with increasing contact time (Fig. 5C ) was not consistent with a parallel reaction scheme (17) and suggested that a two-state model (Scheme 1) would best describe the data. In this model, the inhibitor forms an encounter complex with fIXa (fIXa-NP*), which is then stabilized (fIXa-NP) through a conformational change via an induced fit-type mechanism. Examples of global fits to the two-state model for the K92A and V94A Binding of Wild-type NP2 and NP3 with fIXa-NP2 and NP3 gave strong SPR responses with immobilized fIXa, which were dependent on the presence of calcium ion, while NP4 showed no detectable binding (Fig. 6A) . Binding of NP3 with fIXa was detectable but substantially lower than that for NP2. The reduced affinity for NP3 was due primarily to an elevation in the dissociation rate constant for the encounter complex (k Ϫ1 , Table  I ) of ϳ16-fold, shown most clearly in the normalized ligand release curves of Fig. 5D . A smaller reduction in k 2 of ϳ4-fold was also seen indicating a slower rate of stabilization of the encounter complex. Together, these factors resulted in a difference in the overall dissociation constant of ϳ75-fold (Table I, Fig. 6A) .
Binding of NP2 Mutants with fIXa-The four mutants (positions 92, 94, 97, and 21) showing reduced activity in fXase inhibition assays also showed reduced binding with immobilized fIXa in SPR experiments. As in the enzymatic assays, the largest effect was seen with mutation of K92 which lies at the apex of the E-F loop. The magnitude of the binding effects became smaller as the mutation site was moved along the loop toward ␤-strand F.
The K92A mutant strongly affected the stability of the encounter complex. (Table I, Fig. 6B) . A large increase in k Ϫ1 was seen, as was a decrease in k 1 (Table I ) resulting in a decrease in the overall affinity of ϳ 25-fold. However, k 2 was not dramatically reduced relative to NP2, suggesting that the encounter complex was stabilized in a manner similar to the wild-type protein after it is was formed.
Situated further from the E-F loop apex, the V94A mutation produced a smaller loss of potency than K92A in enzymatic inhibition assays and a correspondingly higher affinity for fIXa in SPR assays (Fig. 6B, Table I ). Nevertheless, the affinity of V94A was reduced relative to NP2, showing a decrease in k 1 but no large increase in k Ϫ1 . Unlike K92A, V94A also had a negative effect on stabilization of the encounter complex (k 2 , Table I ). Following the trend of diminishing effect with distance from the loop apex, the E97A mutant showed a small but detectable decrease in binding relative to NP2 (Table I) . Also, the small reduction of inhibitory potency in the K21A mutant was reflected in SPR results as a decrease in affinity of ϳ5-fold (Table I) .
Combining of the loop E-F mutations in QUAD again produced a larger effect than any single point mutation. Mutations at positions 92, 93, 94, and 97 in a single construct produced a larger effect on fIXa binding than any single mutant (Fig. 6B , Table I ). Relative to NP2, QUAD displayed a large increase in k Ϫ1 of ϳ12-fold, presumably due largely to mutation of Lys 92 , as well as decreases in k 1 and in k 2 (Table I ). These changes in the kinetic constants between NP2 and QUAD result in an increase in the overall dissociation constant of ϳ100-fold (Table I) .
Binding of NPs with fIX-Binding of wild-type NP2, NP3, K92A, V94A, and QUAD with fIX was examined to determine whether any differences in affinity exist between the zymogen and mature protease. The kinetic values obtained by SPR were similar to those obtained for binding of the same proteins with fIXa (Table II, Fig. 6C ). Again, the data were best analyzed using a two-state model. NP2 again bound with the highest affinity with V94A, K92A, NP3, and QUAD showing progressively weaker binding (Table II) .
Solution Binding Experiments-The binding of wild-type NP2 and QUAD with fIXa in solution were compared using isothermal titration calorimetry. The wild-type binding reaction showed a highly favorable enthalpic contribution to the binding energy, while the QUAD reaction showed a much smaller negative binding enthalpy (Fig. 7) . These results suggest that the loss of binding energy with the QUAD mutation may in part be due to a loss of electrostatic interactions between the inhibitor and fIXa in the mutants. At the same time, however, mutation of the combination of charged residues (Lys 92 , Lys 93 , and Glu 97 ) in QUAD to alanine appeared to promote increased hydrophobic interactions between the protease and inhibitor, as evidenced by the positive value for binding entropy in the mutant as compared wild-type NP2. As in the SPR analysis the dissociation constants for QUAD and NP2 differed by ϳ100-fold (Fig. 7) . DISCUSSION NP2 is an insect-derived salivary protein that inhibits the intrinsic fXase by preventing assembly of protein components of the complex on the phospholipid surface (4, 5) . The lack of inhibition of fIXa amidolytic activity suggests that the active site of the protease is not the target (3). Nevertheless, NP2 has been shown to bind directly with fIX and fIXa. Complexation of NP2 with fIXa prevents interaction of the protease with a phospholipid surface, and removal of the fIXa Gla domain abrogates NP2 binding (5) . These observations along with the calcium dependence of binding suggest that the NP2-fIXa interaction point is at or near the Gla domain, a primary site of interaction with the phospholipid membrane (6, 18, 19) , thereby limiting interaction with its protein and/or phospholipid binding partners. Structural studies have shown that the Gla regions of vitamin K-dependent coagulation factors are disordered in the absence of calcium ions (20) suggesting that NP2 requires a folded Gla domain for binding. Direct binding of 
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fVIIIa by the Gla domain of fIX has also been demonstrated, indicating that NP2 may interfere with protein-protein interactions in the fXase complex in addition to protein-lipid interactions (6) .
We found that despite having ϳ80% sequence identity with NP2, NP3 binds fIXa with ϳ100-fold lower affinity and is a correspondingly weak inhibitor of the fXase complex. This protein forms an encounter complex with fIXa as detected by SPR, but the complex is less stable than the NP2-fIXa complex and dissociates rapidly. This leads to a lower equilibrium level of binding and consequently a lower level of inhibition. The relatively small number of sequence differences between NP2 and NP3 allowed us to locate by site-directed mutagenesis structural features important for the formation of a high affinity complex.
Analysis of site-directed surface mutants at residue positions not conserved between NP2 and NP3 clearly implicated the loop connecting the E and F ␤-strands of the ␤-barrel as an important feature in stabilizing the NP2-fIXa complex relative to NP3. Binding was not completely prevented by single mutations or combinations of mutations in this loop, however, suggesting more extensive interaction between the two proteins.
Comparisons of the crystal structures of NP2 and the completely inactive NP4 show that part of the lipocalin ␤-barrel surface containing parts of ␤-strands B, C, D, and E is exposed in NP2 and presumably NP3 but not in NP4 (12, 21, 22) . In the latter protein, this surface is buried by an elongated C-terminal and by loop B-C, which takes on a different conformation in NP4 than in NP2 (Fig. 8) . Since the sequences of NP2 and NP3 are highly similar, and the two proteins presumably have quite similar structures, this exposed face of the ␤-barrel may be important in the formation of the complex seen with NP2 and NP3 but not with NP4. Solvent-exposed amino acid side chains along this face are completely conserved between NP2 and NP3, a fact consistent with the ability of both molecules to form a complex with fIXa.
The E-F loop in NP2 lies at the edge of the exposed face of the ␤-barrel described above and forms a ridge on the surface of the molecule (Fig. 8 ). Here we demonstrate that residues along the ridge, particularly Lys 92 and to a lesser extent Val 94 , are essential for stabilizing the encounter complex fIXa-NP* and facilitating its conversion to fIXa-NP. The large difference in binding enthalpy seen between the wild-type and QUAD complexes with fIXa suggests that mutation of the E-F loop residues may result in a loss of intermolecular hydrogen bonds in the mutant complex relative to wild-type protein.
Comparisons of NP2 and NP3 show a lack of sequence conservation in the E-F loop, with residues 92-97 all differing between the two proteins. This is in fact the longest continuous stretch of non identities in the amino acid alignment of NP2 and NP3. While the weak complex formed by NP3 dissociates quickly, NP2 forms a more stable encounter complex, which is further stabilized by an apparent conformational change. Mutation of Lys 92 , at the apex of loop E-F of NP2, destabilizes the encounter complex as indicated by its increased dissociation rate. Lys 92 forms a hydrogen bond between its ⑀-amino group and the carbonyl oxygen of Phe 176 suggesting that mutation to alanine may affect the conformation or positioning of the E-F loop, the C-terminal, or both. The reduction in inhibitory potency of the K21A mutant is another indication that disruption of the hydrogen bonding network associated with interaction of the C terminus with the ␤-barrel changes the structure of the fIXa interaction surface. Nevertheless, single point mutations in the C-terminal region of NP2 itself had little effect on inhibition, implying a lack of critical contacts between this part of the molecule and fIXa.
The existence of interaction points of NP2 with fIXa beyond the apex of the E-F loop is suggested by the fact that mutation of Val 94 and Glu 97 also reduces binding affinity, albeit less dramatically. The loss in potency becomes smaller as the mutation site is moved away from the apex with residue E97A having only a small effect and E100A being less effective still. Combination of the loop E-F mutations at positions 92, 93, 94, and 97 into a single quadruple mutant (QUAD) construct resulted in a reduction in affinity for fIXa and inhibition of the fXase complex of over 100-fold, and in inhibition of 150-fold, making it similar to NP3 in its binding affinity.
Lipocalin Diversity in Blood Feeding by R. prolixus-The saliva of R. prolixus is rich in proteins belonging to the lipocalin family (23) . Several of these have been shown to have antihemostatic effects, and many others have yet to be characterized (24 -27) . The diversity of lipocalins in the specialized tissue of the salivary gland reflects the well documented ability of the family to tolerate amino acid substitution without disrupting the overall protein fold (28, 29) . R. prolixus has apparently generated, through gene duplication events, a large ensemble of salivary lipocalins that differ in function and perhaps developmental expression pattern (23) . Other insects in the bloodfeeding triatomine group, as well as phylogenetically distant blood feeders such as ticks, also employ diverse arrays of lipocalin molecules to overcome host hemostatic and inflammatory responses.
The NPs are the most abundant proteins in the saliva and in addition to inhibiting coagulation are known to induce vasodilation and inhibit platelet aggregation by releasing nitric oxide into the host blood. The NPs also bind histamine at high affinity, giving them a potential anti-inflammatory role as well. Sequences of expressed sequence tags from a R. prolixus salivary gland library revealed many new NP sequences in addition to the four that were identified initially. Some of these were also detected in a proteomic analysis of salivary gland homogenates (23) . Among the newly discovered NPs was NP7, which has recently been shown to bind with anionic phospholipids on the surface of activated platelets where it acted to inhibit coagulation complex assembly (11) . Membrane binding may also increase the efficiency of NO delivery and histamine binding by keeping the protein associated with areas of platelet and mast cell activation and preventing it from diffusing away from the wound site. All members of the group possess the NO and histamine binding functions, while others have additional functional features. Only NP2 and NP3 are known to bind with fIXa and inhibit the intrinsic coagulation pathway. Why two variants are maintained in the genome with one being much more potent than the other is an open question. Perhaps the broad host range of R. prolixus, which includes numerous species of mammals and birds, would create a need for multiple protein forms that show host related differences in function. Alternatively, NP3 may be an evolutionary intermediate that has not been eliminated from the genome.
